Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 139 $ 64,372,486 $ (7,171) $ (49,582,778) $ 14,782,676
Balance (in Shares) at Dec. 31, 2024 1,394,263        
-stock options 96,985 96,985
-warrants 1,573 1,573
Issuance of common stock at-the-market for cash, net of offering costs $ 44 1,652,701 1,652,745
Issuance of common stock at-the-market for cash, net of offering costs (in Shares) 440,000        
Issuance of common stock for exercise of pre-funded warrants $ 87 784 871
Issuance of common stock for exercise of pre-funded warrants (in Shares) 871,000        
Foreign currency translation 7,171 7,171
Net loss (3,563,238) (3,563,238)
Balance at Mar. 31, 2025 $ 270 66,124,529 (53,146,016) 12,978,783
Balance (in Shares) at Mar. 31, 2025 2,705,263        
Balance at Dec. 31, 2024 $ 139 64,372,486 (7,171) (49,582,778) 14,782,676
Balance (in Shares) at Dec. 31, 2024 1,394,263        
Net loss         (7,279,395)
Balance at Jun. 30, 2025 $ 743 72,034,244 5,631 (56,862,173) 15,178,445
Balance (in Shares) at Jun. 30, 2025 7,443,577        
Balance at Mar. 31, 2025 $ 270 66,124,529 (53,146,016) 12,978,783
Balance (in Shares) at Mar. 31, 2025 2,705,263        
-stock options 57,645 57,645
Issuance of common stock at-the-market for cash, net of offering costs $ 25 358,012 358,037
Issuance of common stock at-the-market for cash, net of offering costs (in Shares) 252,600        
Foreign currency translation 5,631 5,631
Issuance of common stock in May 2025 public offering, net of offering costs $ 357 4,214,149 4,214,506
Issuance of common stock in May 2025 public offering, net of offering costs (in shares) 3,571,428        
Issuance of common stock from the exercise of warrants, net $ 91 1,279,909 1,280,000
Issuance of common stock from the exercise of warrants, net 914,286        
Net loss (3,716,157) (3,716,157)
Balance at Jun. 30, 2025 $ 743 72,034,244 5,631 (56,862,173) 15,178,445
Balance (in Shares) at Jun. 30, 2025 7,443,577        
Balance at Dec. 31, 2025 $ 2,309 125,208,624 18,766 (70,010,461) 55,219,238
Balance (in Shares) at Dec. 31, 2025 23,091,062        
-stock options 138,364 138,364
-warrants 817 817
Issuance of common stock for exercise of pre-funded warrants $ 75 675 750
Issuance of common stock for exercise of pre-funded warrants (in Shares) 750,000        
Issuance of common stock for cashless exercise of pre-funded warrants $ 110 (110)
Issuance of common stock for cashless exercise of pre-funded warrants (in Shares) 1,098,886        
Reclassification to equity of the Placement Agent Warrants Liability 2,294,631 2,294,631
Foreign currency translation 20,596 20,596
Net loss (2,869,482) (2,869,482)
Balance at Mar. 31, 2026 $ 2,494 127,643,001 39,362 (72,879,943) 54,804,914
Balance (in Shares) at Mar. 31, 2026 24,939,948        
Balance at Dec. 31, 2025 $ 2,309 125,208,624 18,766 (70,010,461) 55,219,238
Balance (in Shares) at Dec. 31, 2025 23,091,062        
Net loss         (8,143,334)
Balance at Jun. 30, 2026 $ 3,341 127,980,571 9,570 (78,153,795) 49,839,687
Balance (in Shares) at Jun. 30, 2026 33,414,448        
Balance at Mar. 31, 2026 $ 2,494 127,643,001 39,362 (72,879,943) 54,804,914
Balance (in Shares) at Mar. 31, 2026 24,939,948        
-stock options 328,564 328,564
-warrants 1,377 1,377
Issuance of common stock for exercise of pre-funded warrants $ 847 7,629 8,476
Issuance of common stock for exercise of pre-funded warrants (in Shares) 8,474,500        
Foreign currency translation (29,792) (29,792)
Net loss (5,273,852) (5,273,852)
Balance at Jun. 30, 2026 $ 3,341 $ 127,980,571 $ 9,570 $ (78,153,795) $ 49,839,687
Balance (in Shares) at Jun. 30, 2026 33,414,448